Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives

SIMPLE SUMMARY: Immune checkpoint inhibitors represent a promising treatment choice in many kind of tumours, including hepatocellular carcinoma (HCC). In this review, we provide an overview of the role of these new agents in the management of HCC according to the Barcelona staging system, alongside...

Descripción completa

Detalles Bibliográficos
Autores principales: Federico, Piera, Petrillo, Angelica, Giordano, Pasqualina, Bosso, Davide, Fabbrocini, Antonietta, Ottaviano, Margaret, Rosanova, Mario, Silvestri, Antonia, Tufo, Andrea, Cozzolino, Antonio, Daniele, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603151/
https://www.ncbi.nlm.nih.gov/pubmed/33080958
http://dx.doi.org/10.3390/cancers12103025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603151/
https://www.ncbi.nlm.nih.gov/pubmed/33080958
http://dx.doi.org/10.3390/cancers12103025

Ejemplares similares